Economy

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Valuation According To Analysts

Boasting a price of $6.51, Tetraphase Pharmaceuticals (NASDAQ:TTPH) traded 3.38% higher on the day. Thanks to a rise of nearly 2.13% in the past five days, the stock price is now up 4.86% so far on the year - still in weak territory. BMO Capital Markets reaffirmed a "buy" rating and issued a $12.00 target price on shares of Tetraphase Pharmaceuticals in a research report on Friday, May 5th. The firm earned "Neutral" rating on Wednesday, September 9 by Robert W. Baird. (NASDAQ:TTPH) in a research report report published on Monday morning.

Shares of Tetraphase Pharmaceuticals (NASDAQ TTPH) opened at 6.71 on Wednesday. The firm has "Hold" rating by Brean Capital given on Wednesday, September 9. The stock has "Buy" rating by Suntrust Robinson on Thursday, November 19. Stifel Nicolaus has "Buy" rating and $15 target. The Firm offers a range of advertised brand name and private-label products, including grocery, general merchandise and home, health and beauty care, and pharmacy, which are sold through Company-operated and licensed Retail stores to shoppers and through its Wholesale segment to independent retail customers. However, if the IPI shares go below $3.37 then it would indicate a much weaker market for the company. The Firm operates through five divisions: Alaska, Lower 48, Canada, Europe and North Africa, Asia Pacific and Middle East, and Other International. COP was included in 8 notes of analysts from September 7, 2016. The stock has "Market Perform" rating by Telsey Advisory Group on Tuesday, June 27.

On August 28, 2017 PiperJaffray initiated coverage on the stock by announcing an initial rating of "Overweight". (NYSE:SVU) has "Sector Perform" rating given on Friday, September 9 by RBC Capital Markets. The stock of ConocoPhillips (NYSE:COP) earned "Hold" rating by Jefferies on Wednesday, September 7. About shares traded. SUPERVALU INC. Devon Energy Corp (NYSE:DVN) has risen 13.24% since August 28, 2016 and is uptrending. It has underperformed by 29.39% the S&P500. Bridgeway Capital Management Inc owns 101,845 shares or 0% of their USA portfolio. Thanks to an increase of nearly 3.7% in the past one month, the stock price is now outperforming with 66.75% so far on the year - still in strong zone. Dimensional Fund Advisors LP increased its position in shares of Tetraphase Pharmaceuticals by 580.4% in the fourth quarter.

Since January 1, 0001, it had 0 buys, and 5 sales for $2.53 million activity.

In terms of Tetraphase Pharmaceuticals, Inc. The firm's market cap is $332.36 million. The Firm uses its chemistry technology to create antibiotics for multidrug-resistant infections. The Firm is developing its lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a spectrum intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant gram-negative infections.

Tetraphase Pharmaceuticals (NASDAQ:TTPH) last released its earnings results on Wednesday, August 2nd. It has outperformed by 89.88% the S&P500.

Since March 15, 2017, it had 1 buying transaction, and 0 selling transactions for $82,370 activity. Since an alpha above 1 hints at more gains, investors can predict some further rally scope. Its up 0.06, from 1.02 in 2016Q3.

Tetraphase Pharmaceuticals was boosted by brokerage firms at BidaskClub from a "sell" recommendation to a "hold" recommendation. State Board Of Administration Of Florida Retirement Systems holds 19,717 shares. Geode Capital Management LLC raised its stake in Tetraphase Pharmaceuticals by 17.0% in the first quarter. The company have shares float of 50.28 million. Cipher Capital L P holds 0.45% of its portfolio in SUPERVALU INC. Oxbow Limited Liability Corporation holds 18,580 shares or 0.11% of its portfolio. Parametric Port Ltd Liability Com owns 50,965 shares. Jpmorgan Chase & Co, a New York-based fund reported 4,329 shares. The Massachusetts-based State Street Corporation has invested 0% in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH). (NASDAQ:TTPH) higher to the next line of resistance at $6.93 a share. Rhenman Prtn Asset reported 0.23% stake.

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH)'s latest quote $6.72 $-0.04 3.23% will find technical support in $6.62 a share and a breakdown below this region would be a significantly bearish signal for Tetraphase Pharmaceuticals, Inc. traders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Like this

loading...
loading...

Latest


30 August 2017
Overwatch's Deathmatch & Junkertown Add To The PTR
Overwatch has a bit of a community problem, which was nearly perfectly encapsulated in an image doing the rounds yesterday . In the long term, Blizzard hopes it won't have to police the community so much.

30 August 2017
Flooding knocks out United States refineries, crude hit by supply disruptions
Worries about US refining knocked crude prices lower despite disruptions in oil production elsewhere in the world. The storm has set a rainfall record for tropical cyclones in Texas , the National Weather Service said.

30 August 2017
You need to be online to play Sonic Mania on PC
The developer only updated it to notify everyone about the attached strings after the game had already launched. Sega say "we've noticed an error in the Steam store not mentioning the DRM for Sonic Mania ".

30 August 2017
Signals from Technical Perspective - Microsoft Corporation (NASDAQ:MSFT)
The stock of Microsoft Corporation (NASDAQ:MSFT) earned "Outperform" rating by RBC Capital Markets on Friday, January 27. Mitsubishi Ufj Banking invested in 1.62M shares or 0.37% of the stock. 393 were reported by Benjamin F Edwards Company.

30 August 2017
Bird Group evinces buying Air India's ground handling unit
In an unrelated development, "Air India-specific Alternative Mechanism" is slated to meet later in the evening on Wednesday. For the last fiscal (2016-17), the company was expected to report an improved operating profit margin.

30 August 2017
Advanced Micro Devices, Inc. (NASDAQ:AMD) Shed -1.72% in Pre-Market
The Fund seeks to achieve its objective by investing primarily in master limited partnerships (MLPs) in the energy sector. The insider Su Lisa T sold 125,000 shares worth $1.74 million. $1.57 million worth of Advanced Micro Devices, Inc .

30 August 2017
The Motco Sells 590 Shares of Intercontinental Exchange Inc. (ICE)
Fdx Advisors Inc owns 0.01% invested in Intercontinental Exchange Inc (NYSE:ICE) for 3,773 shares. 78,320 are held by Gam Ag. Caisse De Depot Et Placement Du Quebec invested in 46,550 shares. 33 funds opened positions while 52 raised stakes.

30 August 2017
Hasbro attempts to block sales of LEGO DC Super Hero Girls set
Toy giant Hasbro has filed a lawsuit in an attempt to block DC Comics from using the Bumblebee character in DC Super Hero Girls . Since Hasbro doesn't want to confuse people between the two, the company has sued DC Comics and Warner Bros, Variety reports.

30 August 2017
AT&T Pledges $350000 of aid to impacted communities
The three additional markets joining Austin and Indianapolis include: Waco, Texas; Kalamazoo, Michigan; and South Bend, Indiana. In Austin, AT&T is testing fixed 5G with a auto wash, a church, and some other small businesses, according to the company.

30 August 2017
Price Target Analysis of Activision Blizzard, Inc. (ATVI)
FSB MO now owns 12,157 shares of the company's stock worth $606,000 after buying an additional 90 shares during the last quarter. Its down 0.31, from 1.39 in 2016Q3. (NASDAQ:ATVI) for 86,856 shares. 390 were reported by Valley Natl Advisers Inc.